Division of Urology, VCU Health, Richmond, VA, 23298-0118, USA.
Department of Urology, University of Bari, Bari, Italy.
World J Urol. 2021 Nov;39(11):4175-4182. doi: 10.1007/s00345-021-03741-2. Epub 2021 May 29.
To assess the outcomes of retroperitoneal robot-assisted partial nephrectomy (r-RAPN) in a large cohort of patients with postero-lateral renal masses comparing to those of transperitoneal RAPN (t-RAPN).
Patients with posterior (R.E.N.A.L. score grading P) or lateral (grading X) renal mass who underwent RAPN in six high-volume US and European centers were identified and stratified into two groups according to surgical approach: r-RAPN ("study group") and t-RAPN ("control group"). Baseline characteristics, intraoperative, and postoperative data were collected and compared.
Overall, 447 patients were identified for the analysis. 231 (51.7%) and 216 (48.3%) patients underwent r-RAPN and t-RAPN, respectively. Baseline characteristics were not statistically significantly different between the groups. r-RAPN group reported lower median operative time (140 vs. 170 min, p < 0.001). No difference was found in ischemia time, estimated blood loss, and intraoperative complications. Overall, 47 and 54 postoperative complications were observed in r-RAPN and t-RAPN groups, respectively (20.3 vs. 25.1%, p = 0.9). 1 and 2 patients reported major complications (Clavien-Dindo ≥ III grade) in the retroperitoneal and transperitoneal groups (0.4 vs. 0.9%, p = 0.9). There was no difference in hospital re-admission rate, median length of stay, and PSM rate. Trifecta criteria were achieved in 90.3 and 89.2% of r-RAPN and t-RAPN, respectively (p = 0.7).
r-RAPN and t-RAPN offer similar postoperative, functional, and oncological outcomes for patients with postero-lateral renal tumors. Our analysis suggests an advantage for r-RAPN in terms of shorter operative time, whereas it does not confirm a difference in terms of length of stay, as suggested by previous reports.
评估在 6 个美国和欧洲高容量中心进行的后外侧肾肿瘤的后腹腔镜机器人辅助部分肾切除术(r-RAPN)的结果,并与经腹腔 RAPN(t-RAPN)进行比较。
对在后腹腔镜(R.E.N.A.L. 评分 P 级)或侧腹腔镜(X 级)肾肿瘤中接受 RAPN 的患者进行识别,并根据手术途径分为两组:r-RAPN(“研究组”)和 t-RAPN(“对照组”)。收集并比较基线特征、术中及术后数据。
共纳入 447 例患者进行分析。r-RAPN 和 t-RAPN 组分别有 231 例(51.7%)和 216 例(48.3%)患者。两组间基线特征无统计学差异。r-RAPN 组的中位手术时间较短(140 分钟 vs. 170 分钟,p<0.001)。两组的缺血时间、估计失血量和术中并发症无差异。r-RAPN 和 t-RAPN 组分别有 47 例(20.3%)和 54 例(25.1%)患者发生术后并发症(p=0.9)。腹膜后组和经腹腔组各有 1 例(0.4%)和 2 例(0.9%)患者发生主要并发症(Clavien-Dindo 分级≥III 级)(p=0.9)。两组的住院再入院率、中位住院时间和 PSM 率无差异。r-RAPN 和 t-RAPN 组的 trifecta 标准分别达到 90.3%和 89.2%(p=0.7)。
r-RAPN 和 t-RAPN 为后外侧肾肿瘤患者提供了相似的术后、功能和肿瘤学结果。我们的分析表明,r-RAPN 在手术时间方面具有优势,而在住院时间方面与既往报道结果不同。